Mastering CMC for Biologics - From IND to BLA

  • CategoryOther
  • TypeTutorials
  • LanguageEnglish
  • Total size3 GB
  • Uploaded Byfreecoursewb
  • Downloads12
  • Last checkedJul. 10th '26
  • Date uploadedJul. 09th '26
  • Seeders 0
  • Leechers2

Infohash : 3F854AC2EF1FED66A78251550A2B4F46B4F10738

Mastering CMC for Biologics: From IND to BLA

https://WebToolTip.com

Published 7/2026
MP4 | Video: h264, 1920x1080 | Audio: AAC, 44.1 KHz, 2 Ch
Language: English | Duration: 6h 17m | Size: 2.97 GB

Learn Biologics CMC, CTD Module 3, regulatory strategy, comparability, and global IND, BLA, MAA, and JNDA submissions.

What you'll learn
Develop complete CMC regulatory strategies for biologics from IND/IMPD through BLA, MAA, and JNDA submissions.
Author and critically review CTD Module 3 (Quality) for biologics, including drug substance, drug product).
Design scientifically justified control strategies, comparability plans, process validation, and lifecycle management approaches.
Prepare regulatory briefing packages, respond to health authority questions, and provide practical CMC consulting using real-world examples.
Gain a comprehensive understanding of types of biologics , development, integrated control strategy, process changes, comparability, and lifecycle management.
Learn CMC and regulatory requirements for biosimilars, including analytical similarity, comparability, and global regulatory expectations.
Develop the knowledge and confidence to work in Biologics CMC and Regulatory Affairs across development, submission, and lifecycle management.

Requirements
A basic understanding of pharmaceuticals, biotechnology, life sciences, chemistry, pharmacy, or a related scientific field is helpful but not mandatory.
No prior regulatory affairs experience is required; all fundamental concepts are explained before advancing to complex topics.
Willingness to learn biologics CMC, regulatory strategy, and global submission requirements.
A computer or tablet for viewing lectures and downloading course resources.
Pharma Students or professional with experience in Regulatory Affairs, Quality, Manufacturing, Analytical Development, Process Development, Validation, or Project Management will gain advanced practical insights.

Files:

[ WebToolTip.com ] Mastering CMC for Biologics - From IND to BLA
  • Get Bonus Downloads Here.url (0.2 KB)
    • ~Get Your Files Here ! 1 - Introduction
    • 1 - Introduction to the Course Mastering CMC for Biologics – From IND to BLA (Description).html (1.9 KB)
    • 1 - Introduction to the Course Mastering CMC for Biologics – From IND to BLA.mp4 (17.0 MB)
    10 - CTD Module-3 Quality (CMC) Writing Tips & Strategy (Stage by Stage IND to BLA)
    • 19 - CTD Module 3 Writing Tips (Description).html (1.6 KB)
    • 19 - CTD Module 3 Writing Tips.mp4 (97.4 MB)
    11 - Breakdown On Binding & Non-Binding Regulatory Conditions CTD Module 3 Quality
    • 20 - Established Conditions (PCs) Module 3 Quality (Description).html (1.6 KB)
    • 20 - Established Conditions (PCs) Module 3 Quality.mp4 (102.0 MB)
    • 20 - SECTION_U-10_Breakdown on Binding & Non-Binding Regulatory Conditions.pptx (11.1 MB)
    12 - Deep Dive into CTD MODULE 3 – QUALITY (3.2.S, 3.2.P & Appendices)
    • 21 - Deep Dive into CTD MODULE 3 – QUALITY (3.2.S, 3.2.P & Appendices)-Part 1 (Description).html (1.8 KB)
    • 21 - Deep Dive into CTD MODULE 3 – QUALITY (3.2.S, 3.2.P & Appendices)-Part 1.mp4 (459.4 MB)
    • 22 - Deep Dive into CTD MODULE 3 – QUALITY (3.2.S, 3.2.P & Appendices)-Part 2.mp4 (81.7 MB)
    • 23 - Deep Dive into CTD MODULE 3 – QUALITY (3.2.S, 3.2.P & Appendices)-Part 3.mp4 (95.5 MB)
    • 24 - Deep Dive into CTD MODULE 3 – QUALITY (3.2.S, 3.2.P & Appendices)-Part 4.mp4 (109.9 MB)
    • 25 - Deep Dive into CTD MODULE 3 – QUALITY (3.2.S, 3.2.P & Appendices)-Part 5.mp4 (83.4 MB)
    13 - Biosimilars CMC Regulatory Strategy & Analytical Similarity
    • 26 - Biosimilars (Description).html (1.7 KB)
    • 26 - Biosimilars.mp4 (69.8 MB)
    14 - Strategy A stepwise approach to CMC planning for BLA
    • 27 - Strategy-Planning For BLA (Description).html (1.3 KB)
    • 27 - Strategy-Planning For BLA.mp4 (79.5 MB)
    15 - Real CMC Lessons – From IND to BLA
    • 1 - Practice Test – Mastering CMC for Biologics.html (79.7 KB)
    • 28 - Apply real-world CMC lessons and regulatory insights to BLA (Description).html (1.6 KB)
    • 28 - Apply real-world CMC lessons and regulatory insights to BLA.mp4 (120.7 MB)
    2 - Introduction of Biologics
    • 2 - Introduction of Biologics (Description).html (1.4 KB)
    • 2 - Introduction of Biologics.mp4 (120.0 MB)
    3 - Monoclonal Antibodies - The Model Biologics
    • 3 - Monoclonal Antibodies - The Model Biologics (Description).html (2.0 KB)
    • 3 - Monoclonal Antibodies - The Model Biologics.mp4 (106.8 MB)
    4 - Manufacturing Process of Monoclonal Antibodies
    • 4 - Manufacturing Process of Monoclonal Antibodies (Description).html (1.4 KB)
    • 4 - Manufacturing Process of Monoclonal Antibodies.mp4 (148.0 MB)
    • 5 - Quality by Design (QbD) and Process Validation (Description).html (1.5 KB)
    • 5 - Quality by Design (QbD) and Process Validation.mp4 (211.2 MB)
    5 - Cell Banking in Biologics
    • 6 - Cell Banking in Biologics-Part 1 (Description).html (1.8 KB)
    • 6 - Cell Banking in Biologics-Part 1.mp4 (59.1 MB)
    • 7 - Cell Banking in Biologics-Part 2.mp4 (82.2 MB)
    • 8 - Cell Banking in Biologics-Part 3.mp4 (105.0 MB)
    6 - Biologics Characterization
    • 10 - Biologics Characterization Part-2.mp4 (111.5 MB)
    • 11 - Biologics Characterization Part-3.mp4 (129.8 MB)
    • 9 - Biologics Characterization Part-1 (Description).html (1.9 KB)
    • 9 - Biologics Characterization Part-1.mp4 (104.4 MB)
    7 - Integrated Control Strategy & Comparability
    • 12 - Integrated Control Strategy & Comparability-Part 1 (Description).html (1.9 KB)
    • 12 - Integrated Control Strategy & Comparability-Part 1.mp4 (103.8 MB)
    • 13 - Integrated Control Strategy & Comparability-Part 2 Setting of Specifications.mp4 (65.4 MB)
    • 14 - Integrated Control Strategy & Comparability-Part 3 Comparability Study.mp4 (117.5 MB)
    8 - Stability Studies of Biologics
    • 15 - Stability Studies of Biologics-Part 1 (Description).html (1.7 KB)
    • 15 - Stability Studies of Biologics-Part 1.mp4 (141.0 MB)
    • 16 - Stability Studies of Biologics-Part 2 Extractable and Leachable (E&L).mp4 (26.6 MB)
    • 17 - Stability Studies of Biologics-Part 3 Shipping Qualification.mp4 (50.0 MB)
    9 - CTD Mapping – Modules 1 to 5
    • 18 - CTD Mapping - Module 1 to 5 (Description).html (1.4 KB)
    • 18 - CTD Mapping - Module 1 to 5.mp4 (34.1 MB)
    • Bonus Resources.txt (0.1 KB)

Code:

  • udp://coeus.torrentonline.cc:42069/announce
  • https://edge-team.cc/announce
  • https://tracker.madtia.cc/announce
  • udp://tracker.1h.is:1337/announce
  • udp://tracker.t-1.org:6969/announce
  • udp://open.stealth.si:80/announce
  • udp://whybother.torrentonline.cc:42069/announce
  • udp://obey.torrentonline.cc:42069/announce
  • udp://archive.torrentonline.cc:42069/announce
  • https://tracker.7471.top:443/announce
  • https://tracker.pmman.tech:443/announce
  • https://torrents.tmtime.dev:443/announce
  • http://tracker.moeblog.cn:443/announce
  • http://tracker.lilithraws.org:443/announce
  • http://tr.highstar.shop:80/announce